Ryuji Azuma on Muck Rack

Ryuji Azuma

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ryuji

Contact Ryuji, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and safety of SQ house dust mite sublingual immunotherapy‐tablet in Japanese children

|
By Keisuke Masuyama, Yoshitaka Okamoto, Kazuhiro Okamiya, Ryuji Azuma
| Color Research & Application
The SQ house dust mite (HDM) sublingual immunotherapy (SLIT)‐tablet (TO‐203, Torii, Japan/ALK, Denmark) treatment has been effective against respiratory allergic diseases in patients aged ≥12 years during European, Japanese, and north American trials. This trial was conducted to investigate the efficacy and safety of this treatment in Japanese children (5–17 years) with moderate‐to‐severe HDM allergic rhinitis (AR).
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Ryuji

Contact Ryuji, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified